RLMD — Relmada Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Relmada Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 June 30th	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	9.22	117	212	148	96.3
Net Total Receivables	0.247	0.079	0.086	0.512	0
Prepaid Expenses
Total Current Assets	9.98	118	223	153	97.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.007	0.001	0	—	—
Long Term Notes Receivable
Other Long Term Assets
Total Assets	10.2	118	223	153	97.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.61	12.6	15.1	12.5	12.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	2.61	12.6	15.1	12.5	12.2
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	7.61	106	208	140	85.4
Total Liabilities & Shareholders' Equity	10.2	118	223	153	97.6
Total Common Shares Outstanding
Total Preferred Shares Outstanding